Coagulation Disorder, Blood
9
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
The Effectiveness of a Novel Software Program to Help in ROTEM Interpretation
Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery
Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive Procedures
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections
Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia